股本结构
单位：万股
| 公告日期 | 2024-05-15 | 2024-02-29 | 2024-02-29 | 2023-11-02 | 2023-11-02 | 2023-08-03 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3496.30 | 3462.34 | 3452.47 | 3424.30 | 3424.15 | 3367.91 |
| 普通股本 | 3496.30 | 3462.34 | 3452.47 | 3424.30 | 3424.15 | 3367.91 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-31 | 2024-02-23 | 2023-12-31 | 2023-10-27 | 2023-09-30 | 2023-07-28 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-05-15 | 3496.30 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of common stock from Employee Stock Purchase Plan
Issuance of common stock under stock plans, net of shares withheld for employee taxes
|
2024-03-31 |
| 2024-02-29 | 3462.34 | 未披露 | 定期报告 | 2024-02-23 |
| 2024-02-29 | 3452.47 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock at a weighted average price of $2.66 through at-the-market offering, net of $0.5 million in issuance costs
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from Employee Stock Purchase Plan
|
2023-12-31 |
| 2023-11-02 | 3424.30 | 未披露 | 定期报告 | 2023-10-27 |
| 2023-11-02 | 3424.15 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock from RSU releases
Issuance of common stock from Employee Stock Purchase Plan
Issuance of common stock at a weighted average price of $2.55 through at-the-market offering, net of $0.3 million in issuance costs
|
2023-09-30 |
| 2023-08-03 | 3367.91 | 未披露 | 定期报告 | 2023-07-28 |
| 2023-08-03 | 3340.88 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock at a weighted average price of $2.62 through at-the-market offering, net of $0.1 million in issuance costs
Issuance of common stock from RSU releases
|
2023-06-30 |
| 2023-05-04 | 3108.99 | 未披露 | 定期报告 | 2023-04-28 |
| 2023-05-04 | 3108.89 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock at a weighted average price of $3.68 through at-the-market offering, net of $0.1 million issuance costs
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from Employee Stock Purchase Plan
|
2023-03-31 |
| 2023-04-11 | 3100.33 | 未披露 | 定期报告 | 2023-03-15 |
| 2023-03-02 | 3036.72 | 未披露 | 定期报告 | 2023-02-24 |
| 2023-03-02 | 3029.74 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock from warrant exercises
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from Employee Stock Purchase Plan
|
2022-12-31 |
| 2022-11-03 | 3021.47 | 未披露 | 定期报告 | 2022-10-28 |
| 2022-11-03 | 3021.32 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock from Employee Stock Purchase Plan
Issuance of common stock from RSU releases
|
2022-09-30 |
| 2022-08-08 | 3003.99 | 未披露 | 定期报告 | 2022-08-05 |
| 2022-08-08 | 3003.84 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock from RSU releases
Issuance of common stock from warrant exercises
|
2022-06-30 |
| 2022-05-03 | 2994.06 | 未披露 |
更多>>
from December 31, 2021 to March 31, 2022
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Employee Stock Purchase Plan
|
2022-03-31 |
| 2022-03-10 | 2985.07 | 未披露 | 定期报告 | 2022-03-08 |
| 2022-03-10 | 2977.29 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock at a price of $29.50, net of $9.1 million in issuance costs
Issuance of common stock at a weighted average price of $46.33 through at-the-market offering, net of $0.7 million in issuance costs
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Employee Stock Purchase Plan
|
2021-12-31 |
| 2021-11-09 | 2971.72 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Employee Stock Purchase Plan
|
2021-09-30 |
| 2021-08-04 | 2961.03 | 未披露 | 定期报告 | 2021-07-30 |
| 2021-08-04 | 2960.74 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock from option exercises and RSU releases
Issuance of common stock at a weighted average price of $46.33 through at-the-market offering, net of $0.7 million in issuance costs
|
2021-06-30 |
| 2021-05-13 | 2893.87 | 未披露 | 定期报告 | 2021-05-10 |
| 2021-05-13 | 2891.93 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Issuance of common stock at $10.50 per share, net of $2.0 million in issuance costs
Issuance of Series B-2 convertible preferred stock at $10,500 per share, net of $0.4 million in issuance costs
Issuance of common stock from option exercises
Issuance of common stock from warrant exercises
|
2021-03-31 |
| 2021-04-16 | 2890.59 | 未披露 | 定期报告 | 2021-03-30 |
| 2021-03-04 | 2875.57 | 未披露 | 定期报告 | 2021-03-01 |
| 2021-01-11 | 2382.83 | 未披露 |
更多>>
1.Common Stock Offered By the company 4,237,288 shares of common stock.
2.The number of shares of common stock outstanding immediately following this offering set forth above is based on 19,590,998 shares of common stock outstanding as of September 30, 2020.
|
2021-01-11 |
| 2021-03-05 | 2074.04 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Conversion of Series A and B-2 convertible preferred stock to common stock
Conversion of Series B-1 convertible preferred stock to common stock
Issuance of Series B-1 convertible preferred stock at $10,500 per share, net of $2.6 million in issuance costs
Issuance of Series B-2 convertible preferred stock at $10,500 per share, net of $0.4 million in issuance costs
Issuance of common stock at $10.50 per share, net of $2.0 million in issuance costs
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Life Sci settlement
Issuance of common stock at a weighted average price of $20.97 through at-the-market offering, net of $0.9 million in issuance costs
|
2020-12-31 |
| 2020-11-10 | 1959.53 | 未披露 | 定期报告 | 2020-11-04 |
| 2020-11-10 | 1959.10 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Conversion of Series A and B-2 convertible preferred stock to common stock
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Life Sci settlement
|
2020-09-30 |
| 2020-09-08 | 1950.11 | 未披露 | 定期报告 | 2020-09-04 |
| 2020-08-05 | 1822.94 | 0.18 |
更多>>
From March 31, 2020 to June 30, 2020
Conversion of Series B-1 convertible preferred stock to common stock
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
|
2020-06-30 |
| 2020-05-13 | 1490.73 | 未披露 | 定期报告 | 2020-05-07 |
| 2020-05-13 | 1489.97 | 0.50 |
更多>>
from December 31, 2019 to March 31, 2020
Issuance of Series B-1 preferred stock at $10,500 per share, net of $2.6 million in issuance costs
Issuance of Series B-2 preferred stock at $10,500 per share, net of $0.4 million in issuance costs
Issuance of common stock at $10.50 per share, net of $2.0 million in issuance costs
Issuance of common stock from option exercises
Issuance of common stock from warrant exercises
|
2020-03-31 |
| 2020-04-29 | 1489.97 | 未披露 | 定期报告 | 2020-03-30 |
| 2020-03-11 | 1484.41 | 未披露 | 定期报告 | 2020-03-05 |
| 2020-02-06 | 1234.58 | 未披露 | 定期报告 | 2020-01-15 |
| 2020-03-11 | 1234.48 | 0.12 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of Series A preferred stock at $3,250 per share
Issuance of common stock at $6.50 per share, net of $0.2 million issuance costs
Restricted stock unit release
Conversion of convertible notes to common stock
Conversion of Series C preferred stock to common stock
Issuance of common stock
|
2019-12-31 |
| 2020-01-03 | 1197.14 | 未披露 | 定期报告 | 2019-12-15 |
| 2019-11-07 | 1196.43 | 0.12 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of Series A preferred stock at $3,250 per share
Conversion of Series C preferred stock to common stock
Issuance of common stock
Conversion of convertible notes to common stock
Issuance of common stock at $6.50 per share, net of $0.2 million issuance costs
|
2019-09-30 |
| 2019-08-30 | 267.13 | 未披露 |
更多>>
The business combination was approved by Constellation's stockholders on August 27, 2019 with more than 90% of the voted shares in favor of the business combination. Shortly following the completion of the business combination, Constellation changed its name to DermTech, Inc. and effected a one-for-two reverse stock split of its common stock. Beginning on August 30, 2019, Constellation's common stock and warrants will continue trading on the Nasdaq Capital Market under the ticker symbols "DMTK" and "DMTKW," respectively.
|
2019-08-30 |
| 2019-06-14 | 534.25 | 未披露 |
更多>>
from March 31, 2018 to March 31, 2019
Change in ordinary shares subject to redemption
|
2019-03-31 |
| 2017-11-13 | 1853.00 | 未披露 |
更多>>
From April 1, 2017 to September 30, 2017
Cancellation of ordinary shares issued to initial shareholder
Sale of 14,375,000 Units, net of underwriters discount and offering expenses
Sale of 561,250 Private Units
Ordinary shares subject to redemption
|
2017-09-30 |
| 2017-08-10 | 1613.00 | 未披露 | 定期报告 | 2017-08-10 |
| 2017-08-14 | 1853.00 | 未披露 |
更多>>
From April 1, 2017 to June 30, 2017
Cancellation of ordinary shares issued to initial shareholder
Sale of 14,375,000 Units, net of underwriters discount and offering expenses
Sale of 561,250 Private Units
Ordinary shares subject to redemption
|
2017-06-30 |
| 2017-06-29 | 506.83 | 未披露 | 定期报告 | 2017-06-23 |
| 2017-06-09 | 359.38 | 未披露 | 定期报告 | 2017-05-17 |
| 2017-05-18 | 431.25 | 未披露 | 定期报告 | 2017-03-31 |
| 2014-05-09 | 795.39 | 13346.96 |
更多>>
from December 31,2013 to March 31, 2014
Issuance of Series B preferred stock (at $0.08 per share) upon exercise of warrants (unaudited)
|
2014-03-31 |
From December 31, 2023 to March 31, 2024
Issuance of common stock from Employee Stock Purchase Plan
Issuance of common stock under stock plans, net of shares withheld for employee taxes
From December 31, 2022 to December 31, 2023
Issuance of common stock at a weighted average price of $2.66 through at-the-market offering, net of $0.5 million in issuance costs
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from Employee Stock Purchase Plan
From June 30, 2023 to September 30, 2023
Issuance of common stock from RSU releases
Issuance of common stock from Employee Stock Purchase Plan
Issuance of common stock at a weighted average price of $2.55 through at-the-market offering, net of $0.3 million in issuance costs
From March 31, 2023 to June 30, 2023
Issuance of common stock at a weighted average price of $2.62 through at-the-market offering, net of $0.1 million in issuance costs
Issuance of common stock from RSU releases
From December 31, 2022 to March 31, 2023
Issuance of common stock at a weighted average price of $3.68 through at-the-market offering, net of $0.1 million issuance costs
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from Employee Stock Purchase Plan
From December 31, 2021 to December 31, 2022
Issuance of common stock from warrant exercises
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from Employee Stock Purchase Plan
From June 30, 2022 to September 30, 2022
Issuance of common stock from Employee Stock Purchase Plan
Issuance of common stock from RSU releases
From March 31, 2022 to June 30, 2022
Issuance of common stock from RSU releases
Issuance of common stock from warrant exercises
from December 31, 2021 to March 31, 2022
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Employee Stock Purchase Plan
From December 31, 2020 to December 31, 2021
Issuance of common stock at a price of $29.50, net of $9.1 million in issuance costs
Issuance of common stock at a weighted average price of $46.33 through at-the-market offering, net of $0.7 million in issuance costs
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Employee Stock Purchase Plan
From June 30, 2021 to September 30, 2021
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Employee Stock Purchase Plan
From March 31, 2021 to June 30, 2021
Issuance of common stock from option exercises and RSU releases
Issuance of common stock at a weighted average price of $46.33 through at-the-market offering, net of $0.7 million in issuance costs
From December 31, 2020 To March 31, 2021
Issuance of common stock at $10.50 per share, net of $2.0 million in issuance costs
Issuance of Series B-2 convertible preferred stock at $10,500 per share, net of $0.4 million in issuance costs
Issuance of common stock from option exercises
Issuance of common stock from warrant exercises
1.Common Stock Offered By the company 4,237,288 shares of common stock.
2.The number of shares of common stock outstanding immediately following this offering set forth above is based on 19,590,998 shares of common stock outstanding as of September 30, 2020.
From December 31, 2019 to December 31, 2020
Conversion of Series A and B-2 convertible preferred stock to common stock
Conversion of Series B-1 convertible preferred stock to common stock
Issuance of Series B-1 convertible preferred stock at $10,500 per share, net of $2.6 million in issuance costs
Issuance of Series B-2 convertible preferred stock at $10,500 per share, net of $0.4 million in issuance costs
Issuance of common stock at $10.50 per share, net of $2.0 million in issuance costs
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Life Sci settlement
Issuance of common stock at a weighted average price of $20.97 through at-the-market offering, net of $0.9 million in issuance costs
From June 30, 2020 to September 30, 2020
Conversion of Series A and B-2 convertible preferred stock to common stock
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
Issuance of common stock from Life Sci settlement
From March 31, 2020 to June 30, 2020
Conversion of Series B-1 convertible preferred stock to common stock
Issuance of common stock from option exercises and RSU releases
Issuance of common stock from warrant exercises
from December 31, 2019 to March 31, 2020
Issuance of Series B-1 preferred stock at $10,500 per share, net of $2.6 million in issuance costs
Issuance of Series B-2 preferred stock at $10,500 per share, net of $0.4 million in issuance costs
Issuance of common stock at $10.50 per share, net of $2.0 million in issuance costs
Issuance of common stock from option exercises
Issuance of common stock from warrant exercises
from December 31, 2018 to December 31, 2019
Issuance of Series A preferred stock at $3,250 per share
Issuance of common stock at $6.50 per share, net of $0.2 million issuance costs
Restricted stock unit release
Conversion of convertible notes to common stock
Conversion of Series C preferred stock to common stock
Issuance of common stock
from June 30, 2019 to September 30, 2019
Issuance of Series A preferred stock at $3,250 per share
Conversion of Series C preferred stock to common stock
Issuance of common stock
Conversion of convertible notes to common stock
Issuance of common stock at $6.50 per share, net of $0.2 million issuance costs
The business combination was approved by Constellation's stockholders on August 27, 2019 with more than 90% of the voted shares in favor of the business combination. Shortly following the completion of the business combination, Constellation changed its name to DermTech, Inc. and effected a one-for-two reverse stock split of its common stock. Beginning on August 30, 2019, Constellation's common stock and warrants will continue trading on the Nasdaq Capital Market under the ticker symbols "DMTK" and "DMTKW," respectively.
from March 31, 2018 to March 31, 2019
Change in ordinary shares subject to redemption
From April 1, 2017 to September 30, 2017
Cancellation of ordinary shares issued to initial shareholder
Sale of 14,375,000 Units, net of underwriters discount and offering expenses
Sale of 561,250 Private Units
Ordinary shares subject to redemption
From April 1, 2017 to June 30, 2017
Cancellation of ordinary shares issued to initial shareholder
Sale of 14,375,000 Units, net of underwriters discount and offering expenses
Sale of 561,250 Private Units
Ordinary shares subject to redemption
from December 31,2013 to March 31, 2014
Issuance of Series B preferred stock (at $0.08 per share) upon exercise of warrants (unaudited)